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ttp://dx.doi.org/10.1016/j.ajpath.2016.10.002Mutations in HACD1/PTPLA cause recessive congenital myopathies in humans and dogs. Hydroxyacyl-
coA dehydratases are required for elongation of very long chain fatty acids, and HACD1 has a role in
early myogenesis, but the functions of this striated muscle-speciﬁc enzyme in more differentiated
skeletal muscle remain unknown. Canine HACD1 deﬁciency is histopathologically classiﬁed as a
centronuclear myopathy (CNM). We investigated the hypothesis that muscle from HACD1-deﬁcient
dogs has membrane abnormalities in common with CNMs with different genetic causes. We found
progressive changes in tubuloreticular and sarcolemmal membranes and mislocalized triads and
mitochondria in skeletal muscle from animals deﬁcient in HACD1. Furthermore, comparable mem-
branous abnormalities in cultured HACD1-deﬁcient myotubes provide additional evidence that these
defects are a primary consequence of altered HACD1 expression. Our novel ﬁndings, including T-tubule
dilatation and disorganization, associated with defects in this additional CNM-associated gene pro-
vide a deﬁnitive pathophysiologic link with these disorders, conﬁrm that dogs deﬁcient in HACD1 are
relevant models, and strengthen the evidence for a unifying pathogenesis in CNMs via defective
membrane trafﬁcking and excitation-contraction coupling in muscle. These results build on previous
work by determining further functional roles of HACD1 in muscle and provide new insight into the
pathology and pathogenetic mechanisms of HACD1 CNM. Consequently, alterations in membrane
properties associated with HACD1 mutations should be investigated in humans with related pheno-
types. (Am J Pathol 2017, 187: 441e456; http://dx.doi.org/10.1016/j.ajpath.2016.10.002)Supported by The Myotubular Trust project grant BB/F016891/1
(R.J.P.), Biotechnology and Biological Sciences Research Council stu-
dentship grant BB/F016891/1 (G.L.W., R.J.P.), French National Research
Agency grant ANR-12-JSV1-0005 (L.T., S.B.), French Association Against
Myopathies grants 14577, 15882, 16143 and 17124 (L.T., S.B.), and CNM
Project and the Alliance program grant 22866ZM/10.020 (L.T., S.B.).
Disclosures: None declared.
Current address of G.L.W., Musculoskeletal Biology I, Institute of
Ageing and Chronic Disease, University of Liverpool, Liverpool, United
Kingdom.Centronuclear myopathies (CNMs) are a genetically hetero-
geneous group of congenital myopathies characterized clini-
cally by paresis and skeletal muscle atrophy and histologically
by abnormal centralization of myonuclei.1,2 Genes classically
associated with human CNMs produce proteins involved in
membrane trafﬁcking or excitation-contraction coupling.3
Principally, these proteins include mutations in myotubularin
(MTM1), a phosphoinositide phosphatase4; amphiphysin 2
(BIN1), which promotes and senses membrane curvature5;stigative Pathology. Published by Elsevier Inc.
Y license (http://creativecommons.org/licenses/by/4.0).
Walmsley et aldynamin 2 (DNM2), a protein involved in membrane tubula-
tion and ﬁssion6; and the skeletal muscle ryanodine receptor
(RYR1), the sarcoplasmic reticulum (SR) calcium release
channel.7 Other humanCNMsare associatedwithmutations in
CCDC78,8 SPEG,9 and TTN.10
T-tubules are complex skeletal muscle membrane systems
that conduct action potentials deep within the myoﬁber and
near the internal sarcoplasmic stores at the calcium release
unit or triad. Several causative genes for CNM produce
proteins that associate with T-tubules; hence, the severe
weakness that occurs in CNMs might result from altered
morphologic features of T-tubule or SR membranes, altered
coupling between the voltage-gated dihyropyridine receptor
(DHPR) and ryanodine receptor (RyR1) calcium release
channel, or more direct effects on RyR1 function or
expression.11e22 Additional membrane defects at the
sarcolemma, myoﬁber hypotrophy, and mislocalization of
other proteins involved in membrane repair and recycling all
strengthen the case for a more generalized derangement of
membrane trafﬁcking pathways in CNMs.14,18,19,21,23
Canine HACD1 CNM, an autosomal recessive condition
that was recognized in Labrador retrievers 40 years ago, is the
most common inheritedmyopathy in the breed.24e26 A colony
of affected dogs was established in France in 1992, enabling
more detailed evaluation, and the condition is now widely
accepted as a CNMbased on numerous clinical and pathologic
features in common with CNMs in humans.25,27e29 Affected
dogs do not develop myotatic reﬂexes and have markedly
reduced muscle mass, hypotonia, and paresis compared with
littermates from 1 month of age. Clinical signs are initially
progressive but can stabilize at approximately 1 year of
age.27e30 Their muscle exhibits several characteristic and
progressive features: an early and marked heterogeneity in
ﬁber size with altered oxidative staining followed by type 1
myoﬁber predominance and centralization of nuclei and
ﬁbrosis.27,28,31 Linkage analysis implicated a short inter-
spersed nuclear element insertion in the PTPLA gene (recently
renamedHACD1) as the causativemutation that alters splicing
and reduces expression of normal transcripts.29 These trans-
cripts include a full-length, muscle-speciﬁc isoform named
HACD1-ﬂ (hereafter, for simplicity, termed HACD1) and a
shorter, ubiquitous isoform named HACD1-d5.29
Recently, HACD1 enzyme deﬁciency was also implicated
in a novel human autosomal recessive, congenital myopathy
in an extended, consanguineous Bedouin family.32 HACD1
is highly expressed in developing and mature striated
muscles33e35 and encodes a 3-hydroxyacyl-CoA dehydratase
enzyme with a role in very-long-chain fatty acid (VLCFA)
biosynthesis, as part of the endoplasmic reticulumebound,
elongase complex.34,36,37 VLCFAs are metabolized in muscle
as energy sources but, more importantly, are constituents of
various membrane lipids, including phospholipids and
sphingolipids, which have essential roles in membrane
structure, ﬂuidity, intracellular signaling, and membrane
trafﬁcking.38,39 In vitro, HACD1-deﬁcient myoblasts have
impaired myogenesis35,40 and, more speciﬁcally, defective442myoblast fusion, likely because of altered sarcolemmal lipid
content.40 In yeast and plants,HACD1 homologues (Phs1 and
PASTICCINO2, respectively) are essential for growth and
development.37,41,42
We investigated the hypothesis that canine HACD1 CNM
recapitulates prominent features previously found in related
humanmyopathies and have documented common ﬁndings of
tubuloreticular disorganization and more general membrane
abnormalities combined with mislocalization of other CNM
proteins.11e22 Our work strengthens the evidence for a com-
mon pathogenesis between this myopathy and human CNMs,
validatesHACD1CNM in dogs as a CNMmodel, and reveals
a previously unidentiﬁed role for HACD1 in muscle. Doc-
umenting pathologic consequences associated with HACD1
deﬁciency in CNM provides further insight into CNM path-
ogenesis and conﬁrms a general regulatory role for HACD1
in membrane composition, dynamics, and, speciﬁcally,
T-tubule/SR membrane maintenance in differentiated muscle.
Materials and Methods
Dogs and Sample Collection
Homozygote (affected) (nZ 5) and heterozygote (clinically
normal) (nZ 2) Labrador retrievers (genotyped according to
Pelé et al29), in addition to normal golden retrievers (nZ 2),
were selected at the École nationale vétérinaire d’Alfort
(Maisons-Alfort, France). Experiments on dogs were
approved by the Anses/EnvA/Upec Ethics Committee, and all
care and manipulations were performed in accordance with
national and European legislation on animal experimentation.
Clinical severity varied slightly among the affected dogs, but
all had characteristic signs of paresis, reduction in muscle
mass, and absent myotatic reﬂexes typical of the disease.25e29
Previous work had determined the progression of general
pathologic features in a severely affected muscle, the biceps
femoris26e29; therefore, this muscle was selected for further
evaluation by light and electron microscopy. Biopsy samples
were obtained in a standard manner from dogs under general
anesthesia.28,29 For the evaluation of temporal progression,
dogs from a single litter were biopsied twice (from alternate
sides) at two ages chosen to give a good representation of
pathological features (at 11 months old, during the initial
progressive stage of the disease, and again at 30 months of
age, when dogs would likely have advanced pathologic
features). Additional control samples were obtained from
normal beagle dogs (nZ 4) kept in research colonies within
the UK immediately after their euthanasia (for reasons unre-
lated to this study). Details of all dogs used in this work are
summarized in Supplemental Table S1. This article was
approved by the Royal Veterinary College’s research ofﬁce.
Muscle Histologic Analysis
Routine histologic and histochemical stains were used to
examine the pathologic features in a subset of samples toajp.amjpathol.org - The American Journal of Pathology
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samples and additional test and control samples were ﬁrst
orientated for sectioning on corks with optimum cooling
temperature mountant (Tissue-Tek OCT, Sakura Finetek
UK Ltd., Thatcham, UK) and frozen in liquid nitro-
genecooled isopentane.26,28 Cryosections (10-mm thick-
ness) from dogs detailed in Supplemental Table S1 were
stained with a panel of standard histologic stains: hema-
toxylin and eosin (H&E), modiﬁed Gomori trichrome,
nicotinamide adenine dinucleotide hydride, succinate de-
hydrogenase, cytochrome oxidase, Oil Red O, and acid
phosphatase. The oxidative staining pattern was evaluated
using mitochondria-speciﬁc stains (cytochrome oxidase and
succinate dehydrogenase) in addition to nicotinamide
adenine dinucleotide hydride, which also stains SR.1 The
proportion of centrally nucleated ﬁbers (from a total of
500 ﬁbers per dog taken in at least two ﬁelds of view) was
determined from randomly acquired images obtained using
the 10 objective from H&E-stained cryosections using
ImageJ software version 1.45g (NIH, Bethesda, MD; http://
imagej.nih.gov/ij). Pathologic abnormalities were assessed
[observer (G.L.W.) blinded to genotype] by subjective
scoring (performed on H&E, Gomori trichrome, and cyto-
chrome oxidase, succinate dehydrogenase, and nicotinamideTable 1 Severity and Progression of Pathological Features in Dogs wi
Feature Ctl5 Ctl6 CNM1
Objective counts
H&E - centralized nuclei, % over absolute
count
0.8
6/785
0.4
3/814
14.0
84/601
SDH - abnormal pattern, % over absolute
count
0.3
1/385
0.9
3/331
78.0
199/25
SDH - halo pattern, % over absolute
count
0
0/385
0
0/331
50.6
129/25
Subjective scoring - H&E
Centralized nuclei 0 0 
Variable myoﬁber size 0 0 þþ
Abnormal internal staining pattern 0 0 þþ
Fatty inﬁltration or myoﬁber replacement 0 0 0/þ
Fibrosis 0 0 0
Subjective scoring - trichrome
Abnormal internal staining pattern 0 0 þþ/þ
Fibrosis 0 0 0/þ
Subjective scoring - oxidative stains
COX - abnormal pattern 0 0 þþ
NADH - abnormal pattern 0 0 þþ/þ
SDH - abnormal pattern 0 0 þþ
SDH - halo pattern 0 0 þ/þþ
Subjective scoring - other
Oil Red O - fat 0 0 þ/0
Acid phosphatase positive staining result 0 0 0
Summary of pathologic features as derived from blinded evaluation (G.L.W.) o
determine the percentage of ﬁbers with centralized nuclei and abnormal oxidative
respectively. The lower section of the table gives the results from subjective scor
varied across the section): 0, within normal limits or feature absent; þ, mild (on su
of the ﬁeld of view is affected);þþ, moderate (approximately half of all ﬁbers or o
ﬁbers or of the ﬁeld of view is affected).
CNM, centronuclear myopathy; COX, cytochrome oxidase; Ctl, control; H&E, hem
The American Journal of Pathology - ajp.amjpathol.orgadenine dinucleotide hydride oxidative enzyme stains), and
objective counts of myoﬁbers were performed from
randomly acquired images (obtained using the 20 objec-
tive) of succinate dehydrogenaseestained sections (mini-
mum of 250 ﬁbers per dog taken on three ﬁelds of view or
more) (Table 1).
Immunohistochemical Staining
Immunohistochemistry (IHC) was performed using a se-
lection of antibodies to triad, membrane, cytoskeletal, and
myoﬁbrillar proteins based on prominent ultrastructural
features (see below) and human CNMs. Use of each new
antibody, ﬁxation, and permeabilization protocols was
optimized on trial sections in parallel with control human
muscle sections and additional canine disease controls (not
shown).43 IHC was performed by incubating cryosections
with each primary antibody in a humidiﬁed chamber for 1
hour at room temperature, after rinsing in copious amounts
of phosphate-buffered saline, species-appropriate secondary
antibodies [goat anti-mouse IgG conjugated to Alexa Fluor
488, goat anti-mouse IgG conjugated to Alexa Fluor 594,
and goat anti-rabbit IgG conjugated to Alexa Fluor 594
(Invitrogen, Fisher Scientiﬁc UK Ltd., Loughborough, UK)]th HACD1 CNM at Different Age
CNM2 CNM1-2 CNM2-2 Het2 CNM5
15.6
122/781
38.5
328/851
51.7
429/829
1.7
13/771
43.2
389/511
5
81.5
296/363
85.2
225/264
86.6
219/253
7.1
22/308
90.3
261/289
5
51.0
185/363
16.7
44/264
22.1
56/253
0
0/308
6.9
20/289
 þþ þþ 0/þ þþ
þþþ þþ þþþ  þþþ
þþ þþ/þþþ þþþ 0/þ þþ/þþþ
0/þ þþ/þþþ þþ 0/þ þþþ
0/þ þþ þþ 0/þ þþþ
þþ þþþ þþþ þþþ  þþþ
0/þ þþ þþ  þþþ
þþþ þþ/þþþ þþþ 0 þþþ
þþ þþþ þþþ þþþ 0/þ þþþ
þþ/þþþ þþþ þþþ 0/þ þþþ
þþ  þ/þþ 0 
þ/þþ þþ/þþþ þþ  þþþ
0 0 0 0 0
f stained cryosections from each dog. Objective counts were performed to
staining pattern from random images of H&E and SDH stained cryosections,
ing of other features deﬁned as follows (a range is given where the feature
bjective evaluation this feature is apparent but less than a third of ﬁbers or
f the ﬁeld of view is affected); and þþþ, severe (greater than two-thirds of
atoxylin and eosin; Het2, heterozygote 2; SDH, succinate dehydrogenase.
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Walmsley et alwere applied at 1:1000 in phosphate-buffered saline for 1
hour at room temperature in a light-proof humidiﬁed
chamber. Primary antibodies used were mouse monoclonal
antibodies, unless otherwise stated: RyR1 [34C (Abcam,
Cambridge, UK) 1:100], DHPR [1A (Afﬁnity Bioreagents,
Fisher Scientiﬁc UK Ltd.) 1:100], sarcoplasmic reticulum
Ca2þ-ATPase (SERCA2) [IID8 (Afﬁnity Bioreagents)
1:500], dysferlin [1/7B6 (Leica Novocastra, Leica Bio-
systems, Milton Keynes, UK) 1:25], caveolin 3 [26 (Becton
Dickinson, Oxford, UK) 1:200], desmin [D33 (Dako UK
Ltd., Ely, UK) 1:100], sarcomeric myosin [MF20 (Devel-
opmental Studies Hybridoma Bank, Iowa City, IA) 1:50],
developmental myosin heavy chain [RNMy2/9D2 (Leica
Novocastra) 1:20], dystrophin [Dys2 (Leica Novocastra)
1:20], rabbit polyclonal antibody against BIN1 (iso 8)
(R240621 1:600). To obtain double labeling with multiple
mouse monoclonal antibodies for evaluation of RyR1
(labeled with Alexa Fluor 594) with DHPR and SERCA2
(labeled with Alexa Fluor 488), Zenon antibody labels were
used according to the manufacturer’s instructions (Invi-
trogen, Fisher Scientiﬁc UK Ltd.).
Images were obtained using standardized exposures on a
Leica DMRA2 wide-ﬁeld ﬂuorescent microscope (Leica
Microsystems, Sunnyvale, CA) equipped with an AxioCam
MRm monochrome camera controlled via Axiovision soft-
ware version 4.8.2 (Carl Zeiss Ltd., Cambridge, UK).
Confocal ﬂuorescence microscopy images were captured
using a Leica SP5 confocal laser scanning microscope using
Argon (488), HeNe (594), and Diode (405) lasers.
Electron Microscopy
Each muscle sample was kept chilled until placed in ﬁxative
within 10 minutes of biopsy. The entire sample (approxi-
mately 4-cm long and 1-cm diameter) was initially placed
into 4% glutaraldehyde in 0.1 mmol/L cacodylate buffer
(pH 7.2) (Agar Scientiﬁc, Stanstead, UK) while clamped (to
preserve myoﬁber length). The sample was then dissected
further while in ﬁxative (typically within 10 minutes) to
produce small blocks (1 to 2  2 to 4 mm) oriented with the
long axis running along the myoﬁbers; these samples then
remained in ﬁxative for 2 hours at room temperature.
Samples were then rinsed in a single wash of 0.1 mmol/L
cacodylate buffer and stored at 4C until further processing.
Subsequently, samples were processed in a standard manner
using a mechanical tissue processor (Lynx EL EM Micro-
scopy Tissue Processor, Reichert Jung, Ametek, Munich,
Germany). Tissue was rinsed in 0.1 mmol/L cacodylate
buffer, postﬁxed in 1% osmium tetroxide (Agar Scientiﬁc)
for 2 hours at 4C, dehydrated through graded ethanols and
propylene oxide, and embedded in Araldite resin (Agar
Scientiﬁc) for both transverse and longitudinal sectioning.
Blocks were prepared and semithin sections (500 to 800 nm)
cut and stained with toluidine blue (1% saturated with
borax, TAAB Laboratories Equipment Ltd., Aldermaston,
UK) to select blocks in the desired orientation. Ultrathin444sections (approximately 65-nm thickness) were prepared
from each dog. Sections for imaging were stained with
saturated methanolic uranyl acetate and Reynold’s lead
citrate and examined on a CM10 transmission electron mi-
croscope (Philips, FEI UK Ltd., Cambridge, UK). Images
were obtained using a Kodak Megaview III camera (SIS
GmbH, Munster, Germany).
Imaging, Measurement, and Statistical Analysis of
T-Tubule Morphometry
T-tubules were evaluated morphometrically from electron
micrographs to provide quantitative, objective data. Images
used for T-tubule measurements were captured from lon-
gitudinal sections at 21,000 magniﬁcation in an identical
manner for all samples. Evaluations of shape and size were
performed for >120 T-tubules per dog from a minimum of
ﬁve myoﬁbers (Supplemental Table S1). T-tubules in the
images were circumscribed using a pen tablet (intuos4,
Wacom Europe GmbH, Krefeld, Germany), and parameters
describing shape (circularity, as evaluated by Cowling
et al16) and size were measured for each T-tubule using
ImageJ software. Values were exported into Microsoft Excel
version 14.3.9 (Microsoft Inc., Redmond, WA) and Prism
software version 6.0 (GraphPad Software Inc., La Jolla, CA)
for further analysis and graphical representation. Statistical
analysis, by mixed-effect modeling, was performed with
SPSS software version 2.0.3 (IBM, Portsmouth, UK).
Cell Lines and Tissue Culture
A clonal C2C12 myoblast cell line, stably transfected with
pGIPZ shRNA construct -V2KLHS_5923 (GCTCAT-
TACTCACAGTATA), Thermo Fisher Scientiﬁc, Waltham,
MA] against exon 4 of Hacd1, was evaluated along with an
additional clone expressing a control plasmid (RHS4349).40
These were grown and differentiated in media that contained
2 mg/mL of puromycin to select for stable transgene
expression in the pGIPZ transfected cells. Cultures were
incubated at 37C in 5% CO2. Myoblasts were grown in
Dulbecco’s modiﬁed Eagle’s medium (Sigma-Aldrich
Company Ltd., Dorset, UK) containing 10% heat inacti-
vated fetal bovine serum (PAA Laboratories, Linz, Austria),
2 mmol/L L-glutamine (Invitrogen), 100 IU/mL of peni-
cillin, and 0.1 mg/mL of streptomycin (Sigma-Aldrich
Company Ltd.). Cells were plated into tissue culture ﬂasks
(Nunc, Thermo Fisher Scientiﬁc) or hydrophilic-coated
optical-bottomed dishes (ibiTreat-coated m-dishes, Thistle
Scientiﬁc, Glasgow, UK) for immunocytochemistry and
differentiated at 70% to 80% conﬂuence in Dulbecco’s
modiﬁed Eagle’s medium that contained 4% heat-
inactivated horse serum (PAA Laboratories) and L-gluta-
mine, penicillin, and streptomycin as above. In these
conditions, a partial rescue of the phenotype previously
reported40 enabled this line of Hacd1 knockdown (KD)
myoblasts to form myotubes.ajp.amjpathol.org - The American Journal of Pathology
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the skeletal muscleespeciﬁc Hacd1 transcript between the
control and HACD1-deﬁcient cells. Cells were plated into
ﬂasks and harvested as myoblasts and at 2, 7, and 14 days’
differentiation. Relative expression of Hacd1 compared with
Gapdh was evaluated using a modiﬁed DCT method with
efﬁciency correction.44 Primer pairs speciﬁcally ampliﬁed
the skeletal muscle Hacd1 full-length isoform (forward: 50-
ATGAAGAGAGCGTGGTGCTT-30; reverse: 50-AAGGC-
GGCGTATATTGTGAG-30) for comparison with a house-
keeping gene (Gapdh) (forward: 50-TTGTGATGGGT-
GTGAACCAC-30; reverse: 50-TTCAGCTCTGGGATGA-
CCTT-30 11) that has constant expression during myoblast
differentiation.45 Signiﬁcant Hacd1 KD (approximately
80%) was found between the Hacd1 KD and shRNA
plasmid control cell lines at all time points.Immunocytochemistry and Cell Microscopy
Cells plated into optical dishes (ibiTreat-coated m-dishes)
were rinsed in phosphate-buffered saline and ﬁxed and
permeabilized in methanol and acetone (50:50) for 4 mi-
nutes at 20C (those to be stored before staining were
allowed to air dry and then kept at 20C). Immunostaining
was performed using primary and secondary antibodies as
described for muscle cryosections except nuclei that were
labeled with [Hoechst 33342 (Invitrogen) 1:5000 for 5
minutes at room temperature] before mounting with
Hydromount (Agar Scientiﬁc) using a 19-mm diameter
coverslip (VWR, Lutterworth, UK).
Myotube morphologic features were evaluated (G.L.W.,
blinded to type) by manual counting performed from two
independent experiments per cell line, which generated
eight random 10 ﬁeld-of-view images from standard areas
of RyR1-stained cells at 12 days’ differentiation. Signiﬁ-
cance was evaluated by Fisher exact test (GraphPad Soft-
ware Inc.).Results
Histopathologic features of the dogs used in this study and
representative of the disease are depicted in Figure 1 and
Table 1. On H&E-stained cryosections, abnormal features
of central nucleation, variability in myoﬁber size, ﬁbrosis
and myoﬁber loss, and replacement by fat inﬁltration were
seen in affected HACD1 CNM dogs. Variability in myoﬁber
size with large numbers of small hypotrophic ﬁbers were
prominent from the earlier time point (Figure 1D), whereas
other features, including the proportion of internalized
nuclei, became more apparent with increasing age
(Figure 1, G, J, and M, and Table 1). In healthy dogs,
oxidative stains have a regular distribution on transverse
section within a myoﬁber, and intensity varies based on
ﬁber type between myoﬁbers (type 1 darker staining)
(Figure 1B). Abnormal oxidative staining patterns observedThe American Journal of Pathology - ajp.amjpathol.orgin affected dogs included the absence of a clear ﬁber-type
distribution and the presence of necklace ﬁbers with an
internal, dense-staining ring, running parallel to the sarco-
lemma, lobulated ﬁbers with dense subsarcolemmal mito-
chondrial deposits and many ﬁbers with a halo or peripheral
rim devoid of oxidative staining (Figure 1, E, H, K, and N).
Blinded, subjective scoring (G.L.W.) revealed that most
ﬁbers from HACD1 CNM dogs of all ages had abnormal
internal cytoarchitecture with histologic and oxidative stains
(Table 1). The presence of a peripheral halo was a partic-
ularly prominent feature in 11-month-old dogs (present in
approximately 50% of all ﬁbers) (Figure 1N); in 30-month-
old dogs, this pattern was superseded by more generalized
disorganization. Presumed secondary degenerative changes
(fat inﬁltration and ﬁbrosis) were more common in older
compared with younger dogs (Figure 1, G and J, and
Table 1). Ultrastructural abnormalities observed in affected
dogs with HACD1 CNM included internalized or central-
ized nuclei (Figure 1, F, I, and L), mitochondrial mis-
localization and clumping (Figure 1F), presence of lipid
bodies (Figure 1, I and L), and myoﬁbrillar disorganization
(Figure 1, I and L). These features appeared most severe
in the older animals. No signiﬁcant abnormalities were
detected in the heterozygous or control dogs (Figure 1,
AeC). Prominent features observed by electron microscopy
were probed further by IHC on cryosections from the same
biopsy samples (see below).
Progressive Triad Abnormalities in HACD1-Deﬁcient
Canine CNMs
Recent studies have implicated defective excitation-
contraction coupling in the pathogenesis of CNMs linked
to mutations in genes other than HACD1 and have docu-
mented T-tubule abnormalities as a consistent feature in
human patients and animal models.11e14,16,18e21 Conse-
quently, to support a link between canine HACD1 CNM and
other CNM forms, we evaluated the effect of the HACD1
mutation on muscle membranes in more detail.
Initial subjective evaluation of muscle ultrastructure
revealed a proportion of T-tubules that appeared abnormally
rounded and dilated in affected dogs (Figure 2, AeD).
Objective morphometric evaluation of shape and size
revealed that normal T-tubules were elliptical [means of
medians  SD for circularity, 0.499  0.033 arbitrary units
(AU)] with uniform cross-sectional area (0.0021  0.0003
mm2). In HACD1 CNM 11-month-old dogs, circularity and
variability were increased (0.755  0.045 AU; P < 0.001)
with an insigniﬁcant increase in area (0.0026  0.0005 mm2;
P Z 0.086). At 30 months of age, both circularity
(0.739  0.051 AU; P < 0.001) and cross-sectional area
(0.0051  0.0008 mm2; P < 0.001) were signiﬁcantly
increased (Figure 2, E and F, and Supplemental Figure S1).
In 30-month-old dogs, additional membranous abnormal-
ities were observed, including dilated T-tubules with
luminal contents (Figure 2C).445
Figure 1 Typical pathologic features of HACD1
centronuclear myopathy (CNM) in Labrador retriever
dogs. A, D, G, and J: Representative low-
magniﬁcation images of hematoxylin and eosine
stained 10-mm cryosections from biceps femoris
muscle biopsy samples from a control 40-month-old
dog (A) and HACD1 CNM affected dogs at 11 months
old (D), 30 months old (G), and 14 years old (J).
Note the variability in myoﬁber size and greater
ﬁbrosis and fat inﬁltration in the older CNM-affected
animals. M: At higher magniﬁcation, from a 30-
month-old affected dog in whom prominent path-
ologic features, such as abnormal internal staining
pattern, centralized nuclei, and small hypotrophic
ﬁbers, are evident. B, E, H, and K: Succinate dehy-
drogenase histochemistry of 10-mm cryosections
from biceps femoris muscle biopsy samples from a
control adult (B) and HACD1 CNM affected dogs at
11 months old (E), 30 months old (H), and 14 years
old (K). Note the loss of ﬁber-type checkerboard
pattern and abnormal pattern of oxidative staining.
N: Higher-magniﬁcation image is from an 11-
month-old CNM-affected dog and shows numerous
myoﬁbers with the halo pattern (arrowhead) that
was a common feature. C, F, I, and L: Low-
magniﬁcation muscle ultrastructure showing repre-
sentative features in affected dogs at 11 months old
(F), 30 months old (I), and 14 years old (L)
compared with a control adult dog (C). C: Normal
myonuclei (asterisk) are peripherally located,
whereas in HACD1 CNMeaffected dogs, abnormal
internalization can be seen. These were often
associated with clumps of mitochondria and,
particularly in older dogs, clumps of dark staining
amorphous material (lipid bodies). I: Also notable in
the 30-month-old dog is an area of focal disorga-
nization at the myoﬁber periphery. In addition,
internalized myonuclei can be seen in a chain (as-
terisks). Scale bars: 100 mm (A, D, G, and J); 50 mm
(B, E, H, and K); 10 mm (M, N, and I); 1 mm (C, F,
and L).
Walmsley et alDisorganization of T-Tubule and SR Membrane Markers,
Including BIN1 and RyR1
To evaluate the distribution of triads in muscle from affected
dogs, immunostaining for T-tubule (DHPR) and SR
(SERCA and RyR1) markers was performed on transverse
cryosections from the same biopsy samples used for elec-
tron microscopy. RyR1 and DHPR were observed broadly
to colocalize, and triad staining was disorganized in HACD1
CNM dogs at both ages. In control dogs, a normal, regular,
honeycomb pattern could be seen outlining the bundles of
myoﬁlaments (Figure 3A). In affected dogs, the staining
was disorganized and density was reduced at the periphery,
except for radial remnants directed toward the sarcolemma
(Figure 3, B and C). At 30 months of age, focal areas of
RyR1 and DHPR expression were associated with the pe-
riphery of internalized nuclei or were distributed within the
sarcoplasm, parallel to the sarcolemma (Figure 3C and
Supplemental Figure S2).446BIN1, a T-tubule associated protein with a critical role in
membrane tubulation and T-tubule development46 and
recruitment of partner proteins,47e49 has disorganized
localization in several human CNMs, irrespective of geno-
type.18 Double labeling, with antibodies directed against
BIN1 and RyR1 (Figure 3, DeF, and Supplemental
Figure S3) revealed a similar pattern of disorganization as
seen with DHPR and RyR1 triad staining. Generally, BIN1
and RyR1 colocalized except at the nuclear periphery; some
aggregates were positive for BIN1 but not RyR1. In longi-
tudinal sections, areas of intense BIN1 and DHPR labeling
extended from the centralized nucleus (Figure 3, GeJ). On
reevaluation of the muscle ultrastructure in light of these
ﬁndings, the prominent subsarcolemmal tubular and vesic-
ular membranous structures tended toward a similar radial
alignment and were considered likely to originate from
T-tubule and SR networks (Figure 3, K and L).
Thus, dogs with HACD1 CNM have alterations in
T-tubule ultrastructure, including altered shape andajp.amjpathol.org - The American Journal of Pathology
Figure 2 Triad abnormalities in dogs with
canine HACD1 centronuclear myopathy (CNM). Ae
D: Electron micrographs from longitudinal biceps
femoris muscle sections showing T-tubule appear-
ance from normal canine muscle (17-month-old
dog) (A) and affected dogs at 11 months old (B),
30 months old (C), and 14 years old (D). Insets
show selected representative single T-tubules in
more detail. Note the narrow, elliptical T-tubules
in the normal dog, whereas in dogs with HACD1
CNM, T-tubules appear more rounded and more
dilated as they age. The inset in C shows a T-
tubule with membranous contents. E and F: Results
of objective measurements of T-tubule morphom-
etry performed in >125 T-tubules per dog from at
least ﬁve myoﬁbers: circularity (E) and area (F) are
depicted in bar graphs. A mixed-effect model was
used to assess signiﬁcance; compared with control
dogs, circularity was increased in affected dogs at
both time points, and area was signiﬁcantly
increased at the later time point. Supplemental
Figure S1 shows these results in detail with all
data points plotted for each dog. Data are
expressed as means of medians  SD (E and F).
***P < 0.001. Scale bars: 1 mm (main images);
0.5 mm (insets). AU, arbitrary units.
HACD1-Deﬁcient Myopathy Defectsprogressive dilation. Triad distribution is increasingly
disorganized, with mislocalization especially from areas
close to the sarcolemma.Mitochondrial Mislocalization and Alterations in
Membrane Trafﬁcking and Repair-Associated Proteins
in Affected Dogs
Mitochondrial mislocalization and degeneration (as revealed
by clumping and whorls) were associated with areas of sus-
pected tubuloreticular membranous abnormalities (Figure 3, K
and L). In addition, the peripheral disruption noted on triad
staining appeared analogous to that of the halo pattern detected
with oxidative histochemistry, and this correlation was
conﬁrmed using serial sections (Figure 4, AeG). SERCA2
(Figure 4, GeI, and Supplemental Figure S4) was used as an
additional SR marker that speciﬁcally labels the calcium-
ATPase in type 1 myoﬁbers. This otherwise colocalized
with RyR1, and despite the few remaining type 2 ﬁbers, both
ﬁber types had the same pattern of SR disorganization.
Electron microscopy revealed the presence of sarco-
lemmal abnormalities, including membrane invaginations,
and subsarcolemmal membranous structures, including
vesicles and caveolae (Figure 5, AeD). In 11-month-old
dogs, dysferlin was mislocalized in the cytoplasm in a
number of ﬁbers, diffusely or revealing a peripheral halo
(Figure 5, F and G). Developmental myosin immunolabel-
ing on serial sections revealed that a small proportion of
intensely stained ﬁbers with cytoplasmic mislocalization of
dysferlin were also positive for this marker of regeneration
or immaturity (Figure 5H) (commercially available anti-
bodies for embryonic and neonatal myosins do not detectThe American Journal of Pathology - ajp.amjpathol.orgcanine isoforms50). Adult dogs also had cytoplasmic dys-
ferlin expression (Figure 5I) and an additional pattern, also
seen with dystrophin, which suggested the presence of
invaginated or internalized sarcolemmal membranes
(Figure 5, JeL). Caveolin 3 had a normal distribution in 11-
month-old dogs but had similar abnormalities to dysferlin in
adults (30-month-old and 14-year-old dogs) (results not
shown).
Cytoskeletal Disorganization
In addition to the membranous defects described above, we
also observed more generalized disorganization affecting
cytoskeletal and contractile elements. Z-line abnormalities,
including accumulations and rods, and myoﬁbrillar disor-
ganization were detected (Figure 6, AeF), and the inter-
mediate ﬁlament protein, desmin (Figure 6, GeI), and
sarcomeric myosin (Figure 6, JeL) were mislocalized.
Altered Cellular and Membrane Morphologic Findings in
HACD1-Deﬁcient C2C12 Myotubes
We previously found that myoblast fusion is supported by
HACD1 expression.40 The differentiation conditions used in
this study enabled a partial rescue of the phenotype,
allowing us to maintain sarcomeric myosin-positive
HACD1-deﬁcient myotubes until 12 days of differentia-
tion (Supplemental Figure S5). Both control and Hacd1 KD
lines formed RyR1-positive myotubes (Figure 7, B and E),
but myotubes from the HACD1-deﬁcient line were observed
with intracellular vesicles (Figure 7, A and D), and many
had unusual clusters of nuclei that formed complete or
partial rings (either in a rounded, multinucleate cell or an447
Figure 3 Triad immunohistochemistry. AeF:
Confocal images of transverse sections stained for
dihyropyridine receptor (DHPR) and ryanodine re-
ceptor (RyR1) (AeC) and amphiphysin 2 (BIN1) and
RyR1 (DeF). High-magniﬁcation images of repre-
sentative myoﬁbers from 17-month-old control (A
and D), 11-month-old centronuclear myopathy
(CNM) (B and E), and 30-month-old CNM (C and F)
canine muscle. Note the regular honeycomb pattern
of the staining that outlines the bundles of myoﬁl-
aments in the healthy dog that is disrupted in the
affected dogs with loss of this pattern and reduced
staining intensity, particularly in the ﬁber periphery.
In the older affected dog, this becomes more
prominent with more general disorganization and
focal areas of dense staining. DHPR and RyR appear
to colocalize variably across the ﬁber. GeJ: Confocal
images of longitudinal cryosections of biceps fem-
oris muscle from 40-month-old control (G and I) and
11-month-old CNM-affected (H and J) dogs stained
for BIN1 (G and H) and DHPR (I and J). Note the
accumulations of these T-tubule associated proteins
that extend from internalized nuclei (arrowheads).
Transmission electron micrograph images of trans-
verse sections showing membranous structures of
suspected tubuloreticular origin in 30-month-old
CNM affected dogs. K and L: The images show
varying conﬁgurations, including a subsarcolemmal
rim of vesicular structures and mitochondria (K) and
disorganization with mitochondria and tubular and
vesicular membranes with a radial alignment toward
the sarcolemma (L). Scale bars: 1 mm (AeJ); 10 mm
(K and L).
Walmsley et alarea continuous with a more elongated myotube) (Figure 7,
DeF). These clusters of abnormally positioned myonuclei
were associated with an area of intense RyR1 staining
(Figure 7E). A signiﬁcantly higher proportion of Hacd1 KD
cells had these unusual morphologic ﬁndings compared with
controls (25 of 147 myotubes versus 3 of 229; P < 0.0001).
The skeletal muscleespeciﬁc BIN1 isoform (iso 8) had
similar localization to that of RyR1: control myotubes were
stained relatively homogeneously (Figure 7C), whereas the
Hacd1 KD cells seemed to have focal areas of intense
staining, often associated with clusters of nuclei (Figure 7F).
Discussion
Canine CNM, a highly prevalent, naturally occurring,
recessive disorder in Labrador retrievers, is characterized by448progressive paresis, absent myotatic reﬂexes, reduced
skeletal muscle mass, and histopathologic features sugges-
tive of a CNM, but the pathophysiology has until now been
unclear. In particular, the causative HACD1 mutation’s
effect on muscle ultrastructure and subcellular membrane
systems, which are implicated in CNMs with different ge-
netic causes, has not previously been investigated. Our
work reveals a fundamental role for HACD1 in the main-
tenance of these structures in skeletal muscle. Furthermore,
we found that this large animal model has numerous path-
ologic features that are closely related to those in human
CNMs and smaller laboratory animal CNM models. Our
work helps explain the progressive paresis found in affected
dogs and provides mechanistic insight into a rare but related
human congenital myopathy with closely related clinical
features.32ajp.amjpathol.org - The American Journal of Pathology
Figure 4 Disorganized tubuloreticular membranes and mitochondria mislocalization. Serial biceps femoris muscle cryosections from an 11-month-old
centronuclear myopathy (CNM) affected dog stained with hematoxylin and eosin (H&E) (A), Gomori trichrome (GT) (B), amphiphysin 2 (BIN1) immunohis-
tochemistry (C), succinate dehydrogenase stains (SDH) (D), cytochrome oxidase (COX) (E), and nicotinamide adenine dinucleotide hydride (NADH-TR) (F) and
dual labeling for ryanodine receptor (RyR1) (G) and sarcoplasmic reticulum Ca2þ-ATPase (SERCA2) (H) merged with DAPI (I). CeH: These serial sections reveal
that disorganization of tubuloreticular membranes (C, G, and H) corresponds with the appearance of peripheral ﬁber oxidative halos (DeF). Note that SERCA2
preferentially stains longitudinal sarcoplasmic reticulum in type 1 myoﬁbers; therefore, the type 2 ﬁbers (which are reduced in number in HACD1 CNM affected
dogs) are stained with RyR1 alone and appear red in the merged image (I). Representative control images for comparison can be viewed in other ﬁgures as
follows: H&E and SDH oxidative staining (Figure 1), RyR1, dihyropyridine receptor, and BIN1 (Figure 3). Scale bar Z 50 mm.
HACD1-Deﬁcient Myopathy DefectsCanine HACD1 Deﬁciency and Triad Abnormalities Link
to Proposed Pathogenesis for Other CNMs
In skeletal muscle, numerous highly specialized membrane
systems interact to convey neuronal input via the neuro-
muscular junction, conduct these signals internally via
T-tubules, and store and release calcium to activate the
contractile apparatus and transmit the generated force to the
extracellular matrix. Since 2009, T-tubule abnormalities
have been described consistently in human patients or ani-
mal models with defects in CNM-associated genes15:
MTM1,11e13 BIN1,17,18,21,51 DNM2,14,16,18 hJUMPY,19,52
and RYR1.22,53 In our work, T-tubules from HACD1-
deﬁcient CNM dogs at both ages were more circular in
transverse sections at triads when compared with controls
and became signiﬁcantly larger by 30 months of age. The
initial alteration in shape and subsequent dilation suggest
that T-tubules remodel or undergo degradative morphologic
changes in dogs affected by HACD1 CNM. OurThe American Journal of Pathology - ajp.amjpathol.orgidentiﬁcation of apparent membranous contents within the
lumen of some T-tubules has not been reported in other
myopathies to our knowledge. IHC revealed triad-associated
proteins, DHPR and RyR1, were disorganized and depleted
from the myoﬁber periphery. Our results reveal that, as for
other CNM-associated genes, including MTM1, DNM2, and
BIN1,11,12,14,21,54 HACD1 has a functional role in the
maintenance of T-tubule morphologic features and locali-
zation, either directly or indirectly.
This current study extensively characterized T-tubule
morphologic features in HACD1 CNM; dilated junctional
SR terminals were also documented with prominent mem-
branous structures in the intermyoﬁbrillar space and within
myoﬁbrillar bundles that might represent aberrant SR
membranes (Figures 5, C and D, and 6, D and E). These
abnormalities were probed further by IHC to examine the
T-tubule system and SR distribution, organization, and
physical coupling. Markers for junctional and longitudinal
SR (RyR1 and SERCA2, respectively55) were disorganized,449
Figure 5 Sarcolemmal and internal membra-
nous abnormalities with dysferlin mislocalization.
AeD: Transverse (A and B) and longitudinal (C and
D) electron micrographs from 30-month-old HACD1
centronuclear myopathy (CNM) affected dogs
showing aberrant tubular and vesicular membra-
nous structures, including sarcolemmal membrane
invaginations (white arrow) and subsarcolemmal
vacuoles and caveolae (black arrowheads). EeJ:
Dysferlin immunohistochemistry (green) merged
with DAPI (blue) on transverse cryosections from
control 17-month-old (E), 11-month-old CNM (F),
30-month-old CNM with internal cytoplasmic
staining (I), and 30-month-old CNM with inter-
nalized focal membranous staining (J). GeH: The
boxed area in G shows the region magniﬁed in
image F, which corresponds to a serial section
stained with developmental myosin heavy chain
(dMHC) (H), demonstrating that only a few ﬁbers
with diffuse cytoplasmic staining for dysferlin were
dMHC positive (presumably regenerating) ﬁbers. K
and L: K shows dysferlin alone (from J) alongside a
serial section stained with dystrophin (L),
revealing that internal membranous elements co-
stain with this subsarcolemmal protein (arrow-
heads). Scale bars: 1 mm (AeD); 50 mm (EeL).
Walmsley et alas were proteins localized to T-tubules (DHPR55 and
BIN156). SERCA2 immunostaining also enabled identiﬁ-
cation of type 1 myoﬁbers, and although there is a marked
shift toward oxidative ﬁbers in this condition, SR defects
were identiﬁed in both ﬁber types. RyR1, DHPR, and BIN1
aggregates, similar to those reported here, have been
detected previously in canine models of X-linked MTM13
and BIN1 autosomal recessive CNM.18,21 A recent report
localized MTM1 to junctional SR and concluded that altered
SR remodeling is likely to be a primary cause of intracel-
lular membrane disorganization in myotubular myopathy.20
BIN1 localizes to T-tubules and has a role in their forma-
tion.46,47 HACD1 is believed to reside with other compo-
nents of the elongase complex at endoplasmic reticulum or
SR membranes34,40; however, the localization and speciﬁc
function(s) of VLCFA and related lipids in muscle remain to
be fully characterized. It is not surprising, given the intimate450association between tubuloreticular membrane networks,
that defects in one will affect the other, producing similar
triad abnormalities.
We have also provided evidence of similar membranous
abnormalities in Hacd1 KD C2C12 myotubes, which have
intracellular vacuoles visible by light microscopy and ac-
cumulations of RyR1- and BIN1-positive structures in
conjunction with abnormally positioned nuclei. Although
this intermediate (myotube) developmental stage in C2C12
cells precedes organized tubuloreticular networks, rudi-
mentary structures are present.46,57e59 These results link
HACD1 deﬁciency in dogs with CNM and a cell culture
model to abnormal development and maintenance of triad
membranes and BIN1 mislocalization. These are consistent
features currently considered to be of primary importance in
the pathogenesis of CNMs15,18 and, via postulated
dysfunction of excitation-contraction coupling, provide aajp.amjpathol.org - The American Journal of Pathology
Figure 6 Cytoskeletal abnormalities. AeC:
Ultrastructural z-line abnormalities on longitudinal
sections. A and B: Hazy and disorganized or
smeared z-lines from 11-month-old and 30-month-
old HACD1 centronuclear myopathy (CNM) affected
dogs, respectively C: Accumulations of z-line ma-
terial (rods) in a 14-year-old affected dog (these
were also observed in 30-month-old dogs). DeF:
Myoﬁbrillar disorganization on transverse sections
from 11-month-old (D) and 30-month-old (E) CNM
affected dogs: intermyoﬁbrillar spaces are widened
and bundles of myoﬁlaments disrupted with ac-
cumulations of tubular membranes and glycogen.
F: Transverse myoﬁber section from a 14-year-old
dog revealing the progression into old age,
including a cap of extensive disorganization. GeL:
Immunohistochemistry for desmin (G-I) and sar-
comeric myosin (MF20) (JeL) in 17-month-old
control (G and J), 11-month-old CNM (H and K),
and 30-month-old CNM (I and L) dogs. Note the
disorganization of these intermediate ﬁlament and
contractile apparatus proteins particularly around
the nuclei in CNM-affected dogs. Exposures are not
the same for desmin in all dogs: affected dogs
required shorter exposure times versus normal.
Scale bars: 1 mm (AeF); 20 mm (GeL).
HACD1-Deﬁcient Myopathy Defectscommon mechanism for paresis and hypotonia in this group
of conditions and a potential target for therapeutic
intervention.
Generalized Membranous and Cytoskeletal Defects Are
Apparent in HACD1 CNM
Sarcolemmal membrane abnormalities were also apparent in
CNM-affected dogs, including dilated tubular and vesicular
structures, membrane invaginations, and caveolae, which are
similar to ﬁndings also apparent in other CNMs.18 Dysferlin
and caveolin 3 associate with one another at the sarcolemma
in mature skeletal muscle (Figure 5E): they localize to the
developing T-tubule system and are involved in membrane
trafﬁcking and repair.60e62 Dysferlinopathies are associated
with morphologic abnormalities in T-tubules.61 Several
recent reports have documented abnormal localization of one
or both of these proteins in autosomal CNMs14,21,63: in
particular, the cytoplasmic mislocalization and sarcolemmalThe American Journal of Pathology - ajp.amjpathol.orginvaginations apparent with dysferlin immunostaining in
CNM-affected dogs in this study are similar to those reported
in the autosomal recessive CNM associated with a BIN1
mutation in Great Dane dogs.21 In the current study, the
pattern of cytoplasmic dysferlin staining often has a similar
halo pattern to that observed in triad and oxidative stains,
which might suggest that dysferlin localizes to the T-tubule
system in these ﬁbers for membrane trafﬁcking and repair.
Olby et al64 previously evaluated dysferlin in muscle from
affected Labradors by Western blotting but did not detect any
difference in total expression compared with controls.
Mislocalization of desmin, the major intermediate ﬁla-
ment protein in skeletal muscle, is well documented in
congenital myopathies in general and in CNMs in particular,
where accumulations are associated with the centralized
nucleus.1,2,65,66 A direct role in intermediate ﬁlament orga-
nization and maintenance, independent of defective phos-
phatase activity, has been documented for MTM1.67 Such
cytoskeletal disorganization might also affect mitochondrial451
Figure 7 Morphology of control (AeC) and
Hacd1 knockdown (KD) (DeF) myotubes at 12
days of differentiation. Phase contrast (A and D)
and wide-ﬁeld immunoﬂuorescence for ryanodine
receptor (RyR1) (B and E, magniﬁed in insets) and
amphiphysin 2 (BIN1) (C and F) images showing
the typical appearance of differentiated myotubes
from both cell lines. DeF: Note the presence of
intracellular vesicles (D) and rings of abnormally
positioned nuclei (E and F) in the KD cell line.
Scale bars Z 50 mm (AeF, including insets).
Walmsley et allocalization and dynamics,67 perhaps explaining the
abnormal mitochondrial distribution in HACD1 CNM dogs.
Progressive derangement of the contractile apparatus in
HACD1 CNM dogs was indicated by the Z-line abnormal-
ities, including accumulations and rods, and myoﬁbrillar
disorganization detected by electron microscopy and by the
altered immunoﬂuorescence staining pattern for sarcomeric
myosin. Interestingly, in affected dogs, an area around the
nucleus was often devoid of myoﬁlaments regardless of
positioning; this was not the case in the controls (Figure 6).
BIN1 was recently found to bind both the nuclear envelope
protein nesprin and the microtubule associated protein
CLIP170, implicating a role for this CNM-associated pro-
tein in nuclear positioning.49 The interaction of the cyto-
skeleton and nuclear anchoring proteins, mechanisms that
control myonuclear positioning, and the effect of abnormal
nuclear internalization on muscle function are exciting areas
for further research in CNM.68,69
Cytoarchitectural rearrangements have long been recog-
nized as features of CNM and are often most obvious as
unusual oxidative staining patterns (such as radial strands or
necklaces).70 As in canine CNM, centralized nuclei are
often surrounded by areas devoid of myoﬁlaments that
contain accumulations of mitochondria, glycogen, and SR
membranes.70 Because intracellular systems do not exist in
isolation, disorganization of internal membranes, in partic-
ular the SR, which interacts with numerous organelles,
would be expected to affect positioning of other compart-
ments.20,55 Nonetheless, involvement of CNM-associated
proteins in other complex protein-protein interactions is
being increasingly documented.49,67,69,71 Extensive myoﬁ-
brillar disorganization and nuclear internalization were452initially described as part of the spectrum of congenital
myopathies attributable to RYR1 mutations,72 and more
recently mutations in the TTN gene encoding titin have been
found to cause similar pathologic features.10 A mechanism
for their development from areas of altered Ca2þ homeo-
stasis has been proposed after following the progression of
core development in Ryr1-mutant mice.53,73
Disrupted Lipid Metabolism and Membrane Trafﬁcking
Present a Unifying Pathophysiologic Model for CNMs
There is compelling experimental evidence of aberrant
membrane trafﬁcking from models of classic (MTM1-,
BIN1-, DNM2-, and RyR1-associated) CNMs.5,12,15,18,20,74
We propose that HACD1 deﬁciency affects VLCFA
biosynthesis,32,34,40 leading to altered T-tubule, SR, or
sarcolemmal membrane properties and ultimately progres-
sive dysfunction and degeneration of these muscle mem-
branes. VLCFAs are components of complex lipids with
important structural and signaling roles.75 VLCFA-
substituted phosphatidylinositol is thought to be important
in stabilizing highly curved membranes because the
VLFACs might associate with both sides of the lipid bilayer
and ﬁll areas left void where carbon chains are unopposed
because of extreme curvature.76 Blondelle et al40 recently
documented alterations in VLCFAs and LCFAs and unsat-
urated and saturated fatty acid ratios in HACD1-deﬁcient
models, which reduced plasma membrane ﬂuidity and
resulted in defective membrane fusion and impaired early
myogenesis. A similar mechanism could account for the
abnormalities and progressive degeneration in T-tubule
membranes because fusion is required for T-tubuleajp.amjpathol.org - The American Journal of Pathology
HACD1-Deﬁcient Myopathy Defectsdevelopment (elongation), repair, and maintenance.15 De-
fects in Phs1 (the yeast homologue of HACD1) led to
abnormalities in a number of signaling molecules, in
particular, reduced concentrations of complex sphingolipids
and phosphatidylinositol monophosphates, which notably
include phosphatidylinositol 3-phosphate, the major sub-
strate of myotubularin.34 Membrane defects are emerging as
consistent features in CNM3,18,74; therefore, these ﬁndings
lend additional credence to the inclusion of canine CNM in
this classiﬁcation and validate it as a potential large animal
model for translational research.
Lin et al35 and Blondelle et al40 documented severely
impaired differentiation in HACD1-deﬁcient myoblasts, but,
in contrast, we reveal progressive age-associated muscle
degeneration in CNM-affected dogs. Similarly, other CNM-
associated proteins (MTM1 and BIN1) have roles in both
development12,46,77,78 and maintenance11,13,17,66,79,80 of the
complex membrane systems in mature muscle. In HACD1-
deﬁcient dogs, early differentiation of muscle might be
partially rescued by expression from various paralogous
genes, in particular, other HACD enzymes (such as ubiqui-
tously expressed HACD2/PTPLB or HACD3/PTPLAD1)34
and perhaps maternal delivery of VLCFA via the placenta
and milk.81 We hypothesize that culture conditions used in
this study overcame a defect in cell fusion, allowing us to
detect (at a later stage of differentiation) defective internal
membrane system formation or maintenance.
Mutation of HACD1 in humans has been reported in a
single consanguineous family and resulted in a congenital
myopathy with ﬁber-type disproportion.32 Patients had
neonatal hypotonia and a severely myopathic phenotype that
gradually improve: the single case evaluated in adulthood
had normal gait; however, the absence of myotatic reﬂexes
persisted. This ﬁnding is distinct to the progressive clinical
course observed during growth in dogs with HACD1 deﬁ-
ciency, which is perhaps attributed to different effects of the
two mutations on expression and function of HACD1:
canine CNM is caused by an insertion that affects splicing
and reduces expression of normal isoforms to <1% of
normal,29 whereas in the human family there was a C-
terminal nonsense mutation that reduced expression to 30%
of normal levels and produced an abnormally glycosylated
protein.32 Alternatively, species-related phenotypic varia-
tion may relate to differences in dietary fatty acid compo-
sition and lipid metabolism or muscle development (the
latter has been suggested for MTM1 mutations in humans,
mice, and dogs to explain a similar discrepancy in age of
onset and progression13). Pathologic features associated
with the human HACD1 mutation, in common with canine
CNM, included the presence of hypotrophic ﬁbers and a
marked a predominance of type 1 myoﬁbers.32 An increased
proportion of centralized nuclei was not identiﬁed, but
pathologic description was limited to two patients with
muscle biopsy samples taken at a young age (1 to 2 years).
The proportion of centralized nuclei in affected dogs is often
not markedly elevated at the time of diagnosis31 andThe American Journal of Pathology - ajp.amjpathol.orgincreases progressively over time; the same might be true in
affected human patients as they age. Dogs, mice,40 and
humans32 with loss-of-function mutations in HACD1 have
congenital myopathy with several shared clinical and path-
ologic features: HACD1 should therefore be considered a
candidate gene for congenital ﬁber-type disproportion syn-
dromes and congenital and CNMs in humans and other
species.
In conclusion, dogs with HACD1 deﬁciency have ultra-
structural abnormalities in membranes, in particular in
T-tubules and SR, a hallmark of classic CNM that is thought
to be key factor in human disease symptoms and patho-
genesis. In addition, they also replicate a number of other
prominent pathologic features of this group of disorders.
Our conﬁrmation of this additional gene/protein as a cause
of CNM enhances our understanding of the pathogenesis of
these disorders. Furthermore, cementing the link between
HACD1 deﬁciency and CNM provides mechanistic insight
into the role of HACD/VLCFA in membrane trafﬁcking and
tubuloreticular membrane maintenance in muscle, which is
of fundamental and pressing importance now that this gene
has been linked to a congenital myopathy in humans.32
Finally, our work helps explain the profound and progres-
sive paresis observed in the most prevalent inherited
myopathy of Labrador retrievers, the most popular dog
breed worldwide.
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